So far these guys hit the nail square on the head and just 1 day after posting their analysis. It has dropped to about $4.75 before rallying a little bit.Isn't TA wonderful (sometimes)
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling